Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Nov 2024 for Syros Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Gerald E. Quirk: trading record in brief
Gerald E. Quirk is a declared insider of Syros Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 11 October 2023 to 19 November 2024.
Sales make up the whole of the open-market record (1 sale). The totals do not cover 1 filing with an undisclosed amount. Besides market trades, the filings include 3 option exercises. Since January 2024: no purchases and 1 sale on the market.
On 20 November 2024 came the latest disclosure, an open-market sale in Syros Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gerald E. Quirk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
46,657 shares@ €0.2088100.0% of flowCommon StockSEC:0000950170-24-129381:0
10,000 sharesCommon StockSEC:0000950170-24-111603:0
22,500 sharesCommon StockSEC:0000950170-24-040297:0
22,500 sharesCommon StockSEC:0001209191-23-053246:0
4 of 4 declarations
